Great Lakes Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
JT
Great Lakes Advisors's UTHR Position: Q2 2026 in Review
Great Lakes Advisors reduced its United Therapeutics (UTHR) stake by 49% in Q2 2026, selling an estimated $3.95M and leaving 7,399 shares worth $4.01M. The position accounts for 0.03% of the portfolio, ranked #282.
Great Lakes Advisors first reported a position in UTHR in Q3 2014 and has held it in 16 quarters since. The position peaked at $8.55M in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Great Lakes Advisors held 7,399 shares of United Therapeutics worth $4.01M as of Q2 2026.
- Great Lakes Advisors sold 7,019 United Therapeutics shares in Q2 2026, an estimated $3.95M.
- United Therapeutics made up 0.03% of Great Lakes Advisors's portfolio in Q2 2026, its #282 holding.
- Great Lakes Advisors first reported a position in United Therapeutics in Q3 2014 and has held it in 16 quarters since.
- Great Lakes Advisors's United Therapeutics position peaked at $8.55M in Q1 2026.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.